These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 35409220)

  • 1. Autism Spectrum Disorder: Focus on Glutamatergic Neurotransmission.
    Montanari M; Martella G; Bonsi P; Meringolo M
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics of glutamate and its receptors in autism spectrum disorder.
    Nisar S; Bhat AA; Masoodi T; Hashem S; Akhtar S; Ali TA; Amjad S; Chawla S; Bagga P; Frenneaux MP; Reddy R; Fakhro K; Haris M
    Mol Psychiatry; 2022 May; 27(5):2380-2392. PubMed ID: 35296811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment.
    Rojas DC
    J Neural Transm (Vienna); 2014 Aug; 121(8):891-905. PubMed ID: 24752754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gut microbiota regulates autism-like behavior by mediating vitamin B
    Li Y; Luo ZY; Hu YY; Bi YW; Yang JM; Zou WJ; Song YL; Li S; Shen T; Li SJ; Huang L; Zhou AJ; Gao TM; Li JM
    Microbiome; 2020 Aug; 8(1):120. PubMed ID: 32819434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of glutamatergic and GABAergic genes in the valproic acid-induced rat model of autism: A screening test.
    Lenart J; Augustyniak J; Lazarewicz JW; Zieminska E
    Toxicology; 2020 Jul; 440():152500. PubMed ID: 32428529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cross-talk between nitric oxide and the glutamatergic system in a Shank3 mouse model of autism.
    Hamoudi W; Tripathi MK; Ojha SK; Amal H
    Free Radic Biol Med; 2022 Aug; 188():83-91. PubMed ID: 35716826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Dosage of High-Affinity Kainate Receptor Gene grik4 Alters Synaptic Transmission and Reproduces Autism Spectrum Disorders Features.
    Aller MI; Pecoraro V; Paternain AV; Canals S; Lerma J
    J Neurosci; 2015 Oct; 35(40):13619-28. PubMed ID: 26446216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An autism spectrum disorder-related de novo mutation hotspot discovered in the GEF1 domain of Trio.
    Sadybekov A; Tian C; Arnesano C; Katritch V; Herring BE
    Nat Commun; 2017 Sep; 8(1):601. PubMed ID: 28928363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamatergic and GABAergic gene sets in attention-deficit/hyperactivity disorder: association to overlapping traits in ADHD and autism.
    Naaijen J; Bralten J; Poelmans G; ; Glennon JC; Franke B; Buitelaar JK
    Transl Psychiatry; 2017 Jan; 7(1):e999. PubMed ID: 28072412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamate-mediated signaling and autism spectrum disorders: emerging treatment targets.
    Yang P; Chang CL
    Curr Pharm Des; 2014; 20(32):5186-93. PubMed ID: 24410563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Bacteria Shared by Children and Their Mothers Associate with Developmental Level and Social Deficits in Autism Spectrum Disorder.
    Chen Y; Fang H; Li C; Wu G; Xu T; Yang X; Zhao L; Ke X; Zhang C
    mSphere; 2020 Dec; 5(6):. PubMed ID: 33268567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the Gut Microbiota of Children with Autism Spectrum Disorder.
    Zou R; Xu F; Wang Y; Duan M; Guo M; Zhang Q; Zhao H; Zheng H
    Autism Res; 2020 Sep; 13(9):1614-1625. PubMed ID: 32830918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamatergic synapse in autism: a complex story for a complex disorder.
    Galineau L; Arlicot N; Dupont AC; Briend F; Houy-Durand E; Tauber C; Gomot M; Gissot V; Barantin L; Lefevre A; Vercouillie J; Roussel C; Roux S; Nadal L; Mavel S; Laumonnier F; Belzung C; Chalon S; Emond P; Santiago-Ribeiro MJ; Bonnet-Brilhault F
    Mol Psychiatry; 2023 Feb; 28(2):801-809. PubMed ID: 36434055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing Medications Targeting Glutamatergic Dysfunction in Autism: Progress to Date.
    Fung LK; Hardan AY
    CNS Drugs; 2015 Jun; 29(6):453-63. PubMed ID: 26104862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autism Spectrum Disorder/Intellectual Disability-Associated Mutations in Trio Disrupt Neuroligin 1-Mediated Synaptogenesis.
    Tian C; Paskus JD; Fingleton E; Roche KW; Herring BE
    J Neurosci; 2021 Sep; 41(37):7768-7778. PubMed ID: 34353896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autism Spectrum Disorder: Neurodevelopmental Risk Factors, Biological Mechanism, and Precision Therapy.
    Wang L; Wang B; Wu C; Wang J; Sun M
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct Fecal and Plasma Metabolites in Children with Autism Spectrum Disorders and Their Modulation after Microbiota Transfer Therapy.
    Kang DW; Adams JB; Vargason T; Santiago M; Hahn J; Krajmalnik-Brown R
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33087514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychopathology of Autism Spectrum Disorder: Complex Interplay of Genetic, Epigenetic, and Environmental Factors.
    Bhandari R; Paliwal JK; Kuhad A
    Adv Neurobiol; 2020; 24():97-141. PubMed ID: 32006358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered kynurenine pathway metabolism in autism: Implication for immune-induced glutamatergic activity.
    Lim CK; Essa MM; de Paula Martins R; Lovejoy DB; Bilgin AA; Waly MI; Al-Farsi YM; Al-Sharbati M; Al-Shaffae MA; Guillemin GJ
    Autism Res; 2016 Jun; 9(6):621-31. PubMed ID: 26497015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune-glutamatergic dysfunction as a central mechanism of the autism spectrum disorders.
    Blaylock RL; Strunecka A
    Curr Med Chem; 2009; 16(2):157-70. PubMed ID: 19149568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.